Skip to main content
Equibles

SILVERCREST ASSET MANAGEMENT GROUP LLC

Position in CSTL — Castle Biosciences Inc

CIK 1232395 NEW YORK, NY
Back to CSTL Full portfolio

Position in CSTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,107,865
-$484,669 QoQ
Shares Held
256,095
-4.6% QoQ
Ownership
0.838%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#29
of 176 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 66% Shared 0% None 34%

Common Shares in CSTL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

SILVERCREST ASSET MANAGEMENT GROUP LLC holds $153,900,221 across 13 Diagnostics & Research names. CSTL ranks #7 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 104,046 $52,164,502
2 DGX
Quest Diagnostics Inc
 126,888 $26,893,911
3 RDNT
RadNet, Inc.
 351,756 $21,692,792
4 DHR
Danaher Corp /De/
 98,198 $18,704,755
5 A
Agilent Technologies, Inc.
 79,608 $10,574,330
6 CDNA
CareDx, Inc.
 296,200 $8,441,700
7 CSTL
Castle Biosciences Inc
This page 		256,095 $6,107,865
8 LH
Labcorp Holdings Inc.
 18,131 $5,076,680

All Filings in CSTL

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,107,865 256,095
2026-03-31 $6,592,534 268,535
2025-12-31 $7,974,577 205,002
2025-09-30 $8,376,809 367,888
2025-06-30 $5,716,762 279,959
2025-03-31 $3,980,016 198,802
2024-12-31 $5,328,667 199,950
2024-09-30 $5,758,786 201,921